Logo image of GSUN

GOLDEN SUN HEALTH TECHNOLOGY (GSUN) Stock Fundamental Analysis

USA - NASDAQ:GSUN - KYG4013A1159 - Common Stock

2.64 USD
+0.04 (+1.54%)
Last: 10/16/2025, 4:30:01 PM
Fundamental Rating

1

Overall GSUN gets a fundamental rating of 1 out of 10. We evaluated GSUN against 75 industry peers in the Diversified Consumer Services industry. GSUN may be in some trouble as it scores bad on both profitability and health. GSUN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GSUN had negative earnings in the past year.
GSUN had a negative operating cash flow in the past year.
In multiple years GSUN reported negative net income over the last 5 years.
In multiple years GSUN reported negative operating cash flow during the last 5 years.
GSUN Yearly Net Income VS EBIT VS OCF VS FCFGSUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

GSUN's Return On Assets of -50.01% is on the low side compared to the rest of the industry. GSUN is outperformed by 81.33% of its industry peers.
The Return On Equity of GSUN (-1180.68%) is worse than 82.67% of its industry peers.
Industry RankSector Rank
ROA -50.01%
ROE -1180.68%
ROIC N/A
ROA(3y)-20.23%
ROA(5y)-6.12%
ROE(3y)-223.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSUN Yearly ROA, ROE, ROICGSUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

Looking at the Gross Margin, with a value of 11.08%, GSUN is doing worse than 88.00% of the companies in the same industry.
In the last couple of years the Gross Margin of GSUN has declined.
GSUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.54%
GM growth 5Y-15.35%
GSUN Yearly Profit, Operating, Gross MarginsGSUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

GSUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GSUN has less shares outstanding
GSUN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, GSUN has a worse debt to assets ratio.
GSUN Yearly Shares OutstandingGSUN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
GSUN Yearly Total Debt VS Total AssetsGSUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

GSUN has an Altman-Z score of -0.71. This is a bad value and indicates that GSUN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.71, GSUN is doing worse than 69.33% of the companies in the same industry.
GSUN has a Debt/Equity ratio of 3.74. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.74, GSUN is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.74
Debt/FCF N/A
Altman-Z -0.71
ROIC/WACCN/A
WACC7.42%
GSUN Yearly LT Debt VS Equity VS FCFGSUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

GSUN has a Current Ratio of 0.71. This is a bad value and indicates that GSUN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.71, GSUN is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
GSUN has a Quick Ratio of 0.71. This is a bad value and indicates that GSUN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of GSUN (0.69) is worse than 70.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.69
GSUN Yearly Current Assets VS Current LiabilitesGSUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

GSUN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.26%, which is quite impressive.
Looking at the last year, GSUN shows a very strong growth in Revenue. The Revenue has grown by 65.03%.
Measured over the past years, GSUN shows a decrease in Revenue. The Revenue has been decreasing by -7.70% on average per year.
EPS 1Y (TTM)39.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175%
Revenue 1Y (TTM)65.03%
Revenue growth 3Y-12.23%
Revenue growth 5Y-7.7%
Sales Q2Q%1072.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSUN Yearly Revenue VS EstimatesGSUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GSUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSUN Price Earnings VS Forward Price EarningsGSUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSUN Per share dataGSUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GSUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GOLDEN SUN HEALTH TECHNOLOGY

NASDAQ:GSUN (10/16/2025, 4:30:01 PM)

2.64

+0.04 (+1.54%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)N/A N/A
Earnings (Next)02-02 2026-02-02
Inst Owners0.31%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap5.68M
AnalystsN/A
Price TargetN/A
Short Float %0.72%
Short Ratio0.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 5.68
P/tB 5.68
EV/EBITDA N/A
EPS(TTM)-4.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.06
FCFYN/A
OCF(TTM)-5.01
OCFYN/A
SpS12.43
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.01%
ROE -1180.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.08%
FCFM N/A
ROA(3y)-20.23%
ROA(5y)-6.12%
ROE(3y)-223.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.54%
GM growth 5Y-15.35%
F-Score2
Asset Turnover1.57
Health
Industry RankSector Rank
Debt/Equity 3.74
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.98%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.69
Altman-Z -0.71
F-Score2
WACC7.42%
ROIC/WACCN/A
Cap/Depr(3y)97.54%
Cap/Depr(5y)146.09%
Cap/Sales(3y)2.32%
Cap/Sales(5y)2.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)65.03%
Revenue growth 3Y-12.23%
Revenue growth 5Y-7.7%
Sales Q2Q%1072.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y58.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.29%
OCF growth 3YN/A
OCF growth 5YN/A